Pipeline Assessment

Have Actionable Intelligence to support the of your
candidate through its clinical development journey
Request for solutions

Have Actionable Intelligence to support the development of your candidate through its clinical development journey

  • The collective R&D portfolio of the biopharmaceutical world has been facing a great challenge of innovation depletion.
  • Companies are now starting to think outside the box, work with newer class of candidates, explore newer mechanisms, targets, expression systems and developmental processes.
  • This all, however, one is able to do only if they have full idea of the landscape they are currently working in.

Having understanding of your therapy’s landscape not only provides you a chance to better develop your prospect towards blockbuster journey, but also helps you differentiate yourself in the market that is replete with numerous candidates with average performance.

Our Perspective

DelveInsight’s Pipeline Assessment promises an overarching view of the arena you are interested to gain more knowledge about, by working to provide each and every highlight of the landscape in a report format. Encompassing ready reports already present in our Report Store, our Pipeline Assessment report type provides insights across therapies, MoAs, Drugs, APIs, as well as Launch Insights of drugs in late stage of development to provide understanding of their launch timelines and strategies.

Our Pipeline Assessment Provides You:

  • Detailed Profiling of candidates
  • Reliable assessments of their developmental milestones
  • Unmatched understanding of the therapies in the indication of your choice
  • Key Cross Analysis of candidates
  • Comparative Therapeutic Assessment
  • Understanding of their IP and Regulatory history

Related Insights

Pipeline Assessment study

Pipeline Assessment

A medium pharmaceutical client based in the United States with capabilities in cancer immunotherapy domain involved DelveInsight to analyze current pipeline activity of T-Cell Receptor (TCR) products...

Read More
Product assessment study

Product Assessment

A large pharma client was working to develop their cyclophosphamide API and FD, and was interested to assess competitive products

Read More
Competitive Benchmarking study

Competitive Benchmarking

A large pharmaceutical client based in Europe involved DelveInsight to identify patient advocacy strategies of companies operating in the Pharma sector of the European Union, to benchmark their effort...

Read More
Assest prioritization study

Asset Prioritization

A mid-sized pharma client was working to develop their asset portfolio, and was interested to assess best possible asset for atrial fibrillation

Read More